Trudeau; Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Trudeau; Martin.The latest application filed is for "solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide".

Company Profile

0.27.33

Trudeau; Martin - Shannon CA
Trudeau; Martin - Tewksbury MA
Trudeau; Martin - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 11,291,662 - Hurter , et al. April 5, 2	2022-04-05
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20210251978 - Hurter; Patricia ; et al.	2021-08-19
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20200352930 - Hurter; Patricia ; et al.	2020-11-12
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 10,537,565 - Hurter , et al. Ja	2020-01-21
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20190070162 - Hurter; Patricia ; et al.	2019-03-07
Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-- 3-carboxamide Grant 9,931,334 - Hurter , et al. April 3, 2	2018-04-03
Process For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20170327456 - DEMATTEI; John ; et al.	2017-11-16
Process for making modulators of cystic fibrosis transmembrane conductance regulator Grant 9,751,839 - Demattei , et al. September 5, 2	2017-09-05
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20170231970 - Hurter; Patricia ; et al.	2017-08-17
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 9,670,163 - Hurter , et al. June 6, 2	2017-06-06
Process For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20170096396 - DEMATTEI; John ; et al.	2017-04-06
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20160229806 - Hurter; Patricia ; et al.	2016-08-11
Process for making modulators of cystic fibrosis transmembrane conductance regulator Grant 9,371,287 - DeMattei , et al. June 21, 2	2016-06-21
Process For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20150315151 - DeMattei; John ; et al.	2015-11-05
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 9,139,530 - Hurter , et al. September 22, 2	2015-09-22
Process For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20150073015 - DeMattei; John ; et al.	2015-03-12
Process For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20140350281 - DeMattei; John ; et al.	2014-11-27
Process for making modulators of cystic fibrosis transmembrane conductance regulator Grant 8,835,639 - DeMattei , et al. September 16, 2	2014-09-16
Process For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20140256770 - DeMattei; John ; et al.	2014-09-11
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20140242172 - Hurter; Patricia ; et al.	2014-08-28
Process for making modulators of cystic fibrosis transmembrane conductance regulator Grant 8,765,957 - DeMattei , et al. July 1, 2	2014-07-01
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 8,754,224 - Hurter , et al. June 17, 2	2014-06-17
Process For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20140012003 - DeMattei; John ; et al.	2014-01-09
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20130317060 - Hurter; Patricia ; et al.	2013-11-28
Process for making modulators of cystic fibrosis transmembrane conductance regulator Grant 8,476,442 - DeMattei , et al. July 2, 2	2013-07-02
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Grant 8,410,274 - Hurter , et al. April 2, 2	2013-04-02
Process for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator App 20130072522 - DeMattei; John ; et al.	2013-03-21
Processes And Intermediates App 20130066083 - Tanoury; Gerald J. ; et al.	2013-03-14
Processes and intermediates Grant 8,293,929 - Tanoury , et al. October 23, 2	2012-10-23
Inhibitors of IMPDH enzyme Grant 8,268,873 - Stamos , et al. September 18, 2	2012-09-18
Solid Forms Of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20120214841 - Hurter; Patricia ; et al.	2012-08-23
Process For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20120122921 - DeMattei; John ; et al.	2012-05-17
Processes and Intermediates App 20110071298 - Tanoury; Gerald J. ; et al.	2011-03-24
Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide App 20110064811 - Hurter; Patricia ; et al.	2011-03-17
Processes and intermediates Grant 7,834,200 - Tanoury , et al. November 16, 2	2010-11-16
Process For Making Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20100267768 - DeMattei; John ; et al.	2010-10-21
Caspase Inhibitors And Uses Thereof App 20100105914 - Charrier; Jean-Damien ; et al.	2010-04-29
Caspase inhibitors and uses thereof Grant 7,652,153 - Charrier , et al. January 26, 2	2010-01-26
Processes and intermediates App 20090048429 - Tanoury; Gerald J. ; et al.	2009-02-19
Inhibitors of IMPDH enzyme App 20090030051 - Stamos; Dean ; et al.	2009-01-29
Inhibitors of IMPDH enzyme Grant 7,432,290 - Stamos , et al. October 7, 2	2008-10-07
Gyrase inhibitors and uses thereof Grant 7,414,046 - Grillot , et al. August 19, 2	2008-08-19
Processes and intermediates Grant 7,381,827 - Tanoury , et al. June 3, 2	2008-06-03
Gyrase inhibitors and uses thereof Grant RE40,245 - Grillot , et al. April 15, 2	2008-04-15
Inhibitors of IMPDH enzyme Grant 7,087,642 - Stamos , et al. August 8, 2	2006-08-08
Processes and intermediates App 20060020016 - Tanoury; Gerald J. ; et al.	2006-01-26
Caspase inhibitors and uses thereof App 20050233979 - Charrier, Jean-Damien ; et al.	2005-10-20
Gyrase inhibitors and uses thereof Grant 6,930,116 - Charifson , et al. August 16, 2	2005-08-16
Inhibitors of IMPDH enzyme App 20050148644 - Stamos, Dean ; et al.	2005-07-07
Gyrase inhibitors and uses thereof App 20040043989 - Grillot, Anne-Laure ; et al.	2004-03-04
Inhibitors of IMPDH enzyme App 20040029939 - Stamos, Dean ; et al.	2004-02-12
Gyrase inhibitors and uses thereof App 20040024030 - Charifson, Paul ; et al.	2004-02-05
Gyrase inhibitors and uses thereof Grant 6,632,809 - Grillot , et al. October 14, 2	2003-10-14
Gyrase inhibitors and uses thereof App 20030170858 - Charifson, Paul ; et al.	2003-09-11
Gyrase inhibitors and uses thereof Grant 6,608,087 - Charifson , et al. August 19, 2	2003-08-19
Gyrase inhibitors and uses thereof App 20030119868 - Grillot, Anne-Laure ; et al.	2003-06-26
Inhibitors of IMPDH enzyme Grant 6,498,178 - Stamos , et al. December 24, 2	2002-12-24
Inhibitors of IMPDH enzyme App 20020111378 - Stamos, Dean ; et al.	2002-08-15